Antiaging Quantum Living Inc. (AAQL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Annual

0 400K 800K 1.2M FY25: 817.9K FY26: 1M FY25 FY26

Gross Profit Annual

0 250K 500K 750K FY25: 428.5K FY26: 702.1K FY25 FY26

Operating Income Annual

-900K -600K -300K 0 300K 600K 900K FY25: -790K FY26: -835.4K FY25 FY26

Net Income Annual

-900K -600K -300K 0 300K 600K 900K FY25: -720.4K FY26: -837.6K FY25 FY26

Cost of Revenue Annual

0 150K 300K 450K FY25: 389.4K FY26: 332.3K FY25 FY26

Operating Cash Flow Annual

-1.1M -700K -350K 0 350K 700K 1.1M FY25: -900.3K FY26: -171K FY25 FY26

Free Cash Flow Annual

-45K -30K -15K 0 15K 30K 45K FY22: -42.1K FY22

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M FY25: 30M FY26: 31.5M FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q2 '25: -0.03 Q3 '25: -0.03 Q4 '25: -0.02 Q1 '26: -0.02 Q2 '26: -0.02 Q3 '26: -0.02 Q4 '26: -0.03 Q1 '27: -0.03 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.